[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@drsprs](/creator/twitter/drsprs)
"@JlVlE @NotJanetYellen7 RGEN DHR DIM"  
[X Link](https://x.com/drsprs/status/1974296918164693407) [@drsprs](/creator/x/drsprs) 2025-10-04T02:14Z 2188 followers, XXX engagements


"Are you having trouble sorting out the markets Here are X great contras on Twitter. Back tested and extremely reverse accurate. 👇 Not trying to be mean just truthful my wife is my best trading contra she just doesn't know it. 😂 $TDOC $SE $SNAP $DKNG"  
[X Link](https://x.com/drsprs/status/1618839776408510469) [@drsprs](/creator/x/drsprs) 2023-01-27T05:14Z 2186 followers, 1498 engagements


"Wow I was close thought $XX buy out. $XXXXX + $X CVR = $XXXXX total potentially. #biosquidgames pick $ETNB"  
[X Link](https://x.com/drsprs/status/1968552276932304958) [@drsprs](/creator/x/drsprs) 2025-09-18T05:46Z 2185 followers, 4925 engagements


"$MXCT $CLPT are "toll collectors." At first glance they are attractive since they avoid direct program risk but overall they extract a very small portion of the overall revenue per pt. So they need to have multiple killer apps (commercial) to be scalable + profitable long term. Casgevy is not it. It's clearly not so far. But Maxcyte does have tons of clinical progs in the works do any look like commercial blockbusters $CLPT looks they have X potentially in AMT-130 by $QURE. But look at the financials base case 1000 pts/yr. Uniqure gets 2Mx1000=2B. Clearpoint gets 20Kx1000=20M. Underwhelming."  
[X Link](https://x.com/drsprs/status/1974531283817767270) [@drsprs](/creator/x/drsprs) 2025-10-04T17:45Z 2185 followers, 3140 engagements


"$CAI first Q as public co looks totally different from their private years. Gross margin went from 30s to 60s ASP up 50+% and test volume up XX% (vol is believable). Is this real and/or sustainable Any opinions"  
[X Link](https://x.com/drsprs/status/1955683249352741009) [@drsprs](/creator/x/drsprs) 2025-08-13T17:29Z 2187 followers, 2451 engagements


"For all the chatter that Europe is an aging relic with no innovation European biotechs the past X years have made huge impacts on standard of care in medicine. Argenx $ARGX ➡ any IVIG indication Ascendis $ASND ➡ hypoparathyroidism Abivax $ABVX ➡ effective oral option for UC Adaptimmune $ADAP ➡ synovial sarcoma Immunocore $IMCR ➡ uveal melanoma Merus $MRUS ➡ head and neck cancer and possibly colorectal cancer Uniqure $QURE ➡ Huntington's disease Practice changing medications probably people need to rethink their opinion on European biotech"  
[X Link](https://x.com/drsprs/status/1970878114600501441) [@drsprs](/creator/x/drsprs) 2025-09-24T15:48Z 2187 followers, 10.5K engagements


"@Jeff_Walenta @MartinShkreli Cash is XXXX as of last Q"  
[X Link](https://x.com/drsprs/status/1979298976009765128) [@drsprs](/creator/x/drsprs) 2025-10-17T21:30Z 2187 followers, XX engagements


"@Jeff_Walenta @MartinShkreli Yeah will be 0.50-0.60 lower when they report this Q numbers. I mean last official cash number was XXXX. should be around XXX mid Nov"  
[X Link](https://x.com/drsprs/status/1979591781483438121) [@drsprs](/creator/x/drsprs) 2025-10-18T16:53Z 2188 followers, XX engagements


"@avidresearch @Sports_bios Constant leapfrogging of datasets and innumerable combos and lines of therapies. A nightmare to untangle. AI does actually help to sort things out (I use Gemini and OpenEvidence)"  
[X Link](https://x.com/drsprs/status/1980031738513666498) [@drsprs](/creator/x/drsprs) 2025-10-19T22:02Z 2188 followers, XXX engagements